Estrogen receptor alpha gene (ESR1) polymorphism can contribute to clinical findings in systemic lupus erythematosus patients

Abstract

Background Estrogens have a modulatory effect on several immune responses, many of which are correlated to autoimmune diseases. Estrogens act through binding to their receptors, and an overexpression of these receptors has been identified in patients with different autoimmune diseases. Here we analyzed the association of a putative functional genetic variant in the main estrogen receptor (ERα) gene ( ESR1), and the susceptibility to clinical findings and severity of SLE. Methods A total of 426 individuals (266 healthy controls and 160 SLE patients) were genotyped for the polymorphism rs2234693 in the ESR1 gene. Allele and genotype frequencies were calculated and analyzed between cases and controls using Unphased software. Results The SNP rs2234693 was not associated with SLE per se but the minor allele rs2234693-C was correlated with the presence of nephritis and discoid skin rash. On the other hand, the rs2234693-CC genotype was correlated with the absence of arthritis as well as anti-ANA and anti-RNP autoantibodies. The comprehensive clinical analysis of these patients revealed a more severe status of the disease, characterized by a younger age of onset and higher number of organs involved when compared to European populations. Conclusions Minor allele rs2234693-C was associated with renal and cutaneous involvement, as well as the absence of arthritis, anti-ANA and anti-RNP autoantibodies.

Association between ERα polymorphisms and systemic lupus erythematosus: susceptibility and in silico analysis

“…33 In a recent study, Drehmer et al reported the effect of PvuII C allele on renal and cutaneous involvement in SLE patients. 34 Moreover, in silico analysis was performed to predict the effects of these variations on ERa mRNA splicing.…”

Sex Hormones in Acquired Immunity and Autoimmune Disease

“…ERα is implicated in a pro-inflammatory pathogenic role while ERβ has some anti-inflammatory roles in SLE. Polymorphisms in the ERα ( Esr ) gene have been linked with SLE and found to be significantly associated with the development of disease or age at disease onset, with a higher frequency in childhood-onset vs. adult onset patients or with disease features and severity ( 148 – 152 ).…”

The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology

“…27 ESR1 polymorphism was significantly associated with SLE susceptibility and contributed to clinical manifestations in the overall populations. 28–30 Furthermore, ESR1 could regulate protein 21 expression, which inhibited cytokine production in SLE. 31 Thus, Anti-estrogen drugs had been demonstrated effective in treating SLE.…”